Type to search

ViiV Healthcare Announces US FDA Approval of Apretude (Cabotegravir Extended-release Injectable Suspension), the First and Only Long-acting Injectable Option for HIV Prevention | Pharmtech Focus
New Data Supports the Effectiveness of Adjuvanted Seasonal Influenza Vaccine in Reducing Influenza-Related Hospitalizations and Healthcare Costs in Older Adults | Pharmtech Focus
Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries | Pharmtech Focus